Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

March 24, 2015 Leave a comment 5,973 Views

MOUNTAIN VIEW, Calif., March 23, 2015 /PRNewswire/ — Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced that it has entered into an exclusive agreement with Ludwig Cancer Research for rights to the Smart-seq2 method for single-cell RNA-seq, ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Ludwig Cancer Research

Clontech Gains Access to Smart-seq2 Single-Cell RNA-Seq Technology

Learn more about available bioinformatics tools and pipelines to analyze RNA sequencing data

New search engine for single cell atlases

Yale researchers identify tumor reactive immune cells with RNA sequencing to help fight against advanced melanoma

New algorithm identifies ‘escaping’ cells in single-cell CRISPR screens

RNA sequencing brings hope for endangered wild cats

Mim-tRNAseq – A method that accurately measures the abundance and modification status of different tRNAs

Uncovering the Anti-Myeloma Resistance Files